אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet, uncoated - excipient ingredients: purified talc; colloidal anhydrous silica; pregelatinised maize starch; maize starch; stearic acid; microcrystalline cellulose; citric acid monohydrate - akm rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; stearic acid; citric acid monohydrate; purified talc; maize starch; microcrystalline cellulose; pregelatinised maize starch - pharmacor rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rasagiline mesilate, quantity: 1.56 mg - tablet, uncoated - excipient ingredients: citric acid; purified talc; pregelatinised maize starch; silicon dioxide; maize starch; microcrystalline cellulose; stearic acid - rasagiline is indicated for the symptomatic treatment of idiopathic parkinsons disease (pd) as monotherapy (without concomitant levodopa/decarboxylase inhibitor therapy) or as adjunct therapy (with concomitant levodopa/decarboxylase inhibitor therapy).

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rasagiline mesilate, quantity: 1.56 mg - tablet, uncoated - excipient ingredients: citric acid; stearic acid; pregelatinised maize starch; maize starch; microcrystalline cellulose; silicon dioxide; purified talc - rasagiline is indicated for the symptomatic treatment of idiopathic parkinsons disease (pd) as monotherapy (without concomitant levodopa/decarboxylase inhibitor therapy) or as adjunct therapy (with concomitant levodopa/decarboxylase inhibitor therapy).

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rasagiline mesilate, quantity: 1.56 mg - tablet, uncoated - excipient ingredients: purified talc; stearic acid; citric acid; silicon dioxide; microcrystalline cellulose; pregelatinised maize starch; maize starch - rasagiline is indicated for the symptomatic treatment of idiopathic parkinsons disease (pd) as monotherapy (without concomitant levodopa/decarboxylase inhibitor therapy) or as adjunct therapy (with concomitant levodopa/decarboxylase inhibitor therapy).

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rasagiline mesilate, quantity: 1.56 mg - tablet, uncoated - excipient ingredients: silicon dioxide; microcrystalline cellulose; stearic acid; purified talc; maize starch; citric acid; pregelatinised maize starch - rasagiline is indicated for the symptomatic treatment of idiopathic parkinsons disease (pd) as monotherapy (without concomitant levodopa/decarboxylase inhibitor therapy) or as adjunct therapy (with concomitant levodopa/decarboxylase inhibitor therapy).

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rasagiline mesilate, quantity: 1.56 mg - tablet, uncoated - excipient ingredients: silicon dioxide; pregelatinised maize starch; citric acid; maize starch; stearic acid; microcrystalline cellulose; purified talc - rasagiline is indicated for the symptomatic treatment of idiopathic parkinsons disease (pd) as monotherapy (without concomitant levodopa/decarboxylase inhibitor therapy) or as adjunct therapy (with concomitant levodopa/decarboxylase inhibitor therapy).

סינגפור - אנגלית - HSA (Health Sciences Authority)

lundbeck singapore pte. ltd. - rasagiline mesylate 1.56mg equivalent rasagiline - tablet - rasagiline mesylate 1.56mg equivalent rasagiline 1 mg

מלטה - אנגלית - Medicines Authority

ascend gmbh c/o pollux business center gmbh sebastian-kneipp-straße 41, 60439 frankfurt am main, germany - tablet - rasagiline 1 mg - anti-parkinson drugs

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: stearic acid; purified talc; mannitol; colloidal anhydrous silica; maize starch; pregelatinised maize starch - azilect is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.